Aytu Biopharma Inc share price logo

Aytu Biopharma Inc Share Price

NASDAQ: AYTU

Small Cap

$2.38

+0.08

(+3.48%)

as on

Aytu Biopharma Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.29
    $2.4
    downward going graph

    3.78%

    Downside

    0.84%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.95
    $2.85
    downward going graph

    60.08%

    Downside

    19.75%

    Upside

    downward going graph

Aytu Biopharma Inc share price movements today

Previous Close
$2.30
Open
$2.29
Volume
659.1K
Day's Low - High
$2.29 - $2.4
52 Week Low - High
$0.95 - $2.85

Aytu Biopharma Inc Historical Returns

1 Month Return
+ 0.44 %
3 Month Return
+ 17.95 %
1 Year Return
-10.85 %
3 Year Return
-45.91 %
5 Year Return
-98.99 %

Aytu Biopharma Inc Stock Fundamentals & Key Indicators

Check Aytu Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$20.6M

EPS (TTM)

0.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

6.0M

Revenue (TTM)

81.7M

Profit Margin

2.01%

Return On Equity TTM

160600.00%

Aytu Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aytu Biopharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Aytu Biopharma Inc image
Aytu Biopharma Inc
BUY$20.6M-98.99%NA2.01%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$18.3BNA15.840.36%
Haleon Plc Spon Ads image
Haleon Plc Spon Ads
BUY$44.2BNA21.9313.81%
Neurocrine Biosciences Inc. image
Neurocrine Biosciences Inc.
BUY$14.1B41.32%41.9713.88%
Zoetis Inc. image
Zoetis Inc.
BUY$65.7B-6.55%25.5127.83%

Stock Returns calculator for Aytu Biopharma Inc Stock including INR - Dollar returns

The Aytu Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Aytu Biopharma Inc investment value today

Current value as on today

₹97,363

Returns

₹2,637

(-2.64%)

Returns from Aytu Biopharma Inc Stock

₹7,752 (-7.75%)

Dollar Returns*

₹5,115 (+5.12%)

Analyst Recommendation on Aytu Biopharma Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Aytu Biopharma Inc. Average target price of $9.67

Aytu Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Aytu Biopharma Inc.

What analysts predicted

75.39%UPSIDE

Target Price

$9.67

Current Price

$2.38

Analyzed by

7 Analysts

Target

$9.67

Aytu Biopharma Inc target price $9.67, a slight upside of 75.39% compared to current price of $2.38. According to 7 analysts rating.

Aytu Biopharma Inc Stock's Interest Amongst Investors

Search interest for Aytu Biopharma Inc Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-54% versus previous 30 day period

Aytu Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Total Revenue
26
22
30
17
22
14
17
16
16
18
Gross Profit
17
12
18
13
14
11
11
11
10
12
Operating Income
-4
-9
2
-1
3
-2
-3
0
-1
2
EBITDA
-1
-7
-
0
4
1
-5
3
2
6
Interest Expense
2
1
-
1
1
1
4
0
1
0
Depreciation
2
2
1
2
2
1
1
1
1
1
Income Before Tax
-6
-7
-2
-8
0
-2
-3
1
0
3
Income Tax Expense
1
-1
-
-2
0
0
0
0
0
0
Net Income
-6
-7
-2
-8
0
-2
-4
1
0
3
Net Profit Margin
-25.46%
-31.67%
-7.99%
-45.57%
-0.96%
-20.61%
-25.68%
8.89%
4.86%
21.65%

Aytu Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

Jun 2015
Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Total Revenue
0
2
3
3
7
27
65
96
107
81
Gross Profit
0
1
1
1
5
20
29
46
66
49
Operating Income
-7
-21
-20
-19
-16
-20
-58
-109
-17
-5
EBITDA
-7
-21
-18
-15
-14
-12
-29
-98
-3
-1
Interest Expense
0
5
2
0
-
-
37
147
4
4
Depreciation
-
-
4
2
2
6
9
10
4
8
Income Before Tax
-7
-28
-22
-10
-27
-13
-58
-108
-17
-14
Income Tax Expense
0
8
1
-2
20
-9
0
0
0
1
Net Income
-7
-28
-22
-10
-47
-13
-58
-108
-17
-15
Net Profit Margin
-2950.32%
-1099.73%
-698.67%
-278.36%
-644.33%
-49.29%
-88.81%
-112.53%
-15.88%
-19.56%

Aytu Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Net Income
-7
-2
-8
0
-2
-4
1
0
3
Operating Cash Flow
-2
9
0
0
0
0
-1
2
-6
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
2
-5
-2
0
0
1
0
-2
4
Change in Cash
0
3
-3
0
0
0
0
0
-2

Aytu Biopharma Inc Annual Cash Flow

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Net Income
-28
-22
-10
-27
-13
-58
-110
-17
-15
Operating Cash Flow
-10
-13
-15
-13
-28
-25
-28
-5
-1
Investing Cash Flow
-5
-3
0
-1
-5
-2
-3
0
0
Financing Cash Flow
16
10
22
19
71
30
1
8
-1
Change in Cash
0
-7
6
4
37
1
-30
3
-2

Global Institutional Holdings in Aytu Biopharma Inc

Funds
Holdings
Nantahala Capital Management, LLC
12.11%
Kanen Wealth Management LLC
6.39%
Stonepine Capital Management Llc
5.17%
Renaissance Technologies Corp
0.86%
Armistice Capital, LLC
0.64%
See all

Insights on Aytu Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, AYTU stock has moved up by 95.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 16.22M → 18.45M (in $), with an average increase of 12.1% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 788.0K → 3.99M (in $), with an average increase of 80.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 19.6% return, outperforming this stock by 27.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 87.3% return, outperforming this stock by 131.3%

About Aytu Biopharma Inc

aytu bioscience is a specialty healthcare company focused on developing and commercializing novel products in the field of urology. aytu is initially concentrating on prostate cancer, male premature ejaculation and male infertility and plans to expand into other urological indications for which there are significant medical needs. the company currently markets prostascint®, an fda-approved radioimaging agent indicated to detect prostate specific membrane antigen (psma) in the assessment and staging of prostate cancer. the company’s most advanced therapeutic is zertane™, an oral therapeutic entering phase 3 clinical studies in the united states as an as needed treatment for premature ejaculation (pe). aytu is also conducting clinical trials with the company’s mioxsys™ system as a novel, point-of-care diagnostic system with the potential to become a standard of care in the diagnosis and management of male infertility.
OrganisationAytu Biopharma Inc
HeadquartersDenver Corporate Center III, Denver, CO, United States, 80237
IndustryConsumer Services
CEOMr. Joshua R. Disbrow
E-voting on sharesClick here to vote

Key Management of Aytu Biopharma Inc

Name

Title

Ms. Margaret Cabano

Vice President of Operations

Mr. Joshua R. Disbrow

CEO & Director

Mr. Jarrett T. Disbrow Ph.D.

Chief Business Officer

Mr. Greg Pyszczymuka

Chief Commercial Officer

Mr. Ryan J. Selhorn CPA

CFO, Corporate Secretary & Treasurer

FAQs

What is Aytu Biopharma Inc share price today?

Aytu Biopharma Inc share price today is $2.38 as on at the close of the market. Aytu Biopharma Inc share today touched a day high of $2.4 and a low of $2.29.

What is the 52 week high and 52 week low for Aytu Biopharma Inc share?

Aytu Biopharma Inc share touched a 52 week high of $2.85 on and a 52 week low of $0.95 on . Aytu Biopharma Inc stock price today i.e. is closed at $2.38,which is 16.49% down from its 52 week high and 150.53% up from its 52 week low.

What is Aytu Biopharma Inc's market capitalisation today?

Aytu Biopharma Inc market capitalisation is $0.00T as on .

How to invest in Aytu Biopharma Inc Stock (AYTU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aytu Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aytu Biopharma Inc Shares that will get you 0.6303 shares as per Aytu Biopharma Inc share price of $2.38 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Aytu Biopharma Inc Stock (AYTU) from India?

Indian investors can start investing in Aytu Biopharma Inc (AYTU) shares with as little as ₹88.25 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.50 in Aytu Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Aytu Biopharma Inc share’s latest price of $2.38 as on September 13, 2025 at 1:29 am IST, you will get 4.2017 shares of Aytu Biopharma Inc. Learn more about fractional shares .

What are the returns that Aytu Biopharma Inc has given to Indian investors in the last 5 years?

Aytu Biopharma Inc stock has given -98.99% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?